HK inno.N said on Monday that it launched its gastroesophageal reflux disease (GERD) drug K-CAB Tab. 50mg (ingredient: tegoprazan) in Indonesia which will be distributed under the product name, TEZA, in Indonesia via Kalbe Farma.HK inno.N's K-CAB is a new drug for GERD in the P-CAB class and has the
Assets related to Hanmi Pharm's platform technology Orascovery, an oral drug discovery platform technology, will be transferred to C-Mer Eye Care Holdings, a Hong Kong-based healthcare company.Athenex, Hanmi's U.S. partner, which declared bankruptcy in May, recently signed an agreement to transfer i
Leclaza (ingredient: lazertinib) demonstrated consistently strong progression-free survival (PFS) outcomes in both global and domestic clinical trials, with its particular ability to be used as a first-line treatment for epidermal growth factor receptor (EGFR) mutated non-small cell lung cancer (NSC
NKMax, a biotechnology company, has announced a significant development in its partnership with China's Shoukang Group. The two companies have signed a letter of commitment (LOC), outlining Shoukang Group's investment of $50 million (65.3 billion won) through third-party allotment.This investment wi
Teva Handok's severe asthma treatment Cinqair (reslizumab) crossed the threshold of the Drug Benefit Evaluation Committee (DBEC) Thursday, six years after it won approval from the Ministry of Food and Drug Safety.The seventh DBEC meeting this year also recognized the appropriateness of reimbursement
The Asia Pacific Primary Liver Cancer Expert Meeting (APPLE) 2023 returned offline emphasizing the need to prevent the causes of liver cancer such as hepatitis B and C, as rapidly changing treatment guidelines make the new liver cancer treatments difficult to apply in clinical settings.“The treatmen
Global private equity firm Blackstone, which has been the subject of news reports in Korean outlets regarding the potential sale of Korea's leading drug distributor Geo-Young Corp., said it has not yet made a decision on the matter.Blackstone holds the majority stake in Geo-Young Corp., through the
KoBioLabs said on Thursday it terminated the technology transfer agreement with Kolmar Korea Holdings for two immune-modulating drug candidates, KBL382 and KBL1027.Accordingly, Kolmar Korea Holdings will return the global clinical development, licensing, and commercialization rights of the two immun
AstraZeneca Korea said Sidapvia (ingredient: dapagliflozin 10 mg, sitagliptin 100 mg) received approval from the Ministry of Food and Drug Safety on June 30 for the treatment of type 2 diabetes in adults aged 18 years and older.Sidapvia is a combination of Forxiga (dapagliflozin), the best-selling s
The first trial of the botulinum toxin (BTX) license revocation case between Medytox and the Ministry of Food and Drug Safety (MFDS) ended with a victory for Medytox.The Daejeon District Court ruled in favor of Medytox in the first sentencing hearing of the BTX license revocation administrative laws
The pharmaceutical industry and the government have joined forces to tap into Vietnam’s medicine market.The Ministry of Food and Drug Safety said it had organized a public-private drug industry support team comprising the government, academia, and industry, which would visit Vietnam from Thursday to
Caregen said it has signed a contract to supply up to $143 million worth of ProGsterol (ingredient: deglusterol), a health-functional food that has a mechanism to suppress insulin resistance and increase insulin sensitivity, preventing damage to beta cells in the pancreas that secrete insulin.Accord
Bukwang Pharmaceutical said it has launched Taflead Tab. , a cheaper generic drug of Gilead's Vemlidy, to treat hepatitis B.Developed by Samjin Pharmaceutical, Taflead Tab. is a hepatitis B treatment composed of tenofovir alafenamide hemimalate, which is a salt-modified generic drug that changes hem
Dongkook Pharmaceutical said Monday that it has signed a business agreement with GC Biopharma for the domestic sales and marketing of its insulin biosimilar Glargia Prefilled Pen (insulin glargine).Under the agreement, Dongkook will be responsible for the domestic sales and marketing of Glargia. Gla
Korean cardiologists emphasized the need to reimburse AstraZeneca’s SGLT-2 inhibitor Forxiga in treating heart failure with preserved ejection fraction (HFpEF) at a press conference celebrating the indication expansion of Forxiga on Monday."Given the clinical benefits of Forxiga, it warrants expande
GC Biopharma said on Monday that it signed a deal with Blau Farmaceutica, a Brazilian partner, to supply its immunoglobulin blood product, Immune Globulin Intravenous (IVIG-SN5%), to Brazil until 2028.More specifically, GC Biopharma will supply blood products estimated at $90.48 million (approximate
Medytox has recently received a series of patent invalidation or registration refusal decisions related to its new botulinum toxin (BTX) product at home and abroad. Market attention is on how this will affect the company’s biologics license application (BLA) for the new BTX, MT10109L, scheduled for
Sanofi's third-generation antihistaminic Allegra Tab 120 mg (fexofenadine hydrochloride) has been suspended from advertising for two months.The Ministry of Food and Drug Safety issued a two-month advertising suspension for Allegra Tab on June 23. The suspension period is from June 27 to Aug. 26.Hand
In a shocking revelation, it has come to light that Minoxidil Tab. Hyundai, the company's hypertension treatment which is more famous for its off-label use as a hair loss treatment, has inadvertently been labeled as Tamirin ER Tab., a dementia treatment, and given to dementia patients.The impact of
SK biopharmaceuticals has decided to acquire Proteovant Sciences, a joint venture established in the U.S.The company said in a public filing Friday that it would acquire 40 million shares of Proteovant valued at about 62 billion won ($47.5 million). SK biopharmaceuticals will acquire the shares with